Search Results - "Visser, Wieke C. H."

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer by Visser, Wieke C. H., de Jong, Hans, Steyaert, Sandra, Melchers, Willem J. G., Mulders, Peter F. A., Schalken, Jack A.

“…Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer (PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The…”
Get full text

Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics by Visser, Wieke C. H., de Jong, Hans, Smit, Frank P., Shrivastava, Jolly, Poole, Jason C., Leenders, William P. J., Melchers, Willem J. G., Mulders, Peter F. A., Schalken, Jack A.

“…Microarray and Single-Molecule Molecular Inversion Probe (smMIP)-based targeted RNA sequencing are two RNA profiling platforms for identifying…”
Get full text

Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis by Visser, Wieke C H, de Jong, Hans, Melchers, Willem J G, Mulders, Peter F A, Schalken, Jack A

“…In the diagnosis and prognosis of prostate cancer (PCa), the serum prostate-specific antigen test is widely used but is associated with low specificity…”
Get full text